Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
4.5K
Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

14.6K
Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.6K
Structures of Solids02:22

Structures of Solids

17.9K
Solids in which the atoms, ions, or molecules are arranged in a definite repeating pattern are known as crystalline solids. Metals and ionic compounds typically form ordered, crystalline solids. A crystalline solid has a precise melting temperature because each atom or molecule of the same type is held in place with the same forces or energy. Amorphous solids or non-crystalline solids (or, sometimes, glasses) which lack an ordered internal structure and are randomly arranged. Substances that...
17.9K
Membrane Domains01:18

Membrane Domains

7.2K
The membrane domains concentrate specific lipids and proteins at one place within the membrane, which helps in cell signaling, adhesion, and other critical cellular processes. These domains can differ in size, composition, function, and lifespan.
Protein Domains
The membrane comprises a group of distinct proteins responsible for carrying out a cell's specific function. For example, the plasma membrane of the human sperm, or a single germ cell, contains a unique set of proteins in the...
7.2K
Three Developmental Domains01:29

Three Developmental Domains

1.1K
Human development is typically examined across three main domains: physical, cognitive, and socio-emotional. These domains represent the significant areas of change and continuity throughout the lifespan, from infancy to late adulthood.
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure of the NAT10 acetyltransferase and mechanism of tRNA acetylation.

Nature communications·2026
Same author

An S752D activation loop mutation dynamically primes Muscle-Specific Kinase for activation.

The Biochemical journal·2026
Same author

Tetflupyrolimet shows selectivity for plant dihydroorotate dehydrogenase over Aspergillus orthologs.

Scientific reports·2026
Same author

A role for condensin-mediator interaction in mitotic chromosome organization.

Nature communications·2026
Same author

Lipids regulate epidermal growth factor receptor activation by its ligands.

Biochemical Society transactions·2026
Same author

The role of kinase domain dimerization in EGFR activation.

Structure (London, England : 1993)·2025

Related Experiment Video

Updated: Feb 6, 2026

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella
11:31

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella

Published on: November 30, 2018

7.9K

Structural Basis for MARK1 Kinase Autoinhibition by Its KA1 Domain.

Ryan P Emptage1, Mark A Lemmon2, Kathryn M Ferguson2

  • 1Department of Biochemistry and Biophysics and the Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Structure (London, England : 1993)
|August 14, 2018
PubMed
Summary

The kinase associated-1 (KA1) domain inhibits MARK1 kinase activity by binding to its kinase domain. This structural insight into kinase autoinhibition may offer new therapeutic targets for Alzheimer's disease and cancers.

Keywords:
C-terminal domainMARK1Tau proteinactivation segmentautoinhibitioninhibitory mechanismserine/threonine protein kinasestructural biologyαD helix

More Related Videos

Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO
13:02

Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO

Published on: December 28, 2019

7.9K
Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.6K

Related Experiment Videos

Last Updated: Feb 6, 2026

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella
11:31

Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella

Published on: November 30, 2018

7.9K
Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO
13:02

Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO

Published on: December 28, 2019

7.9K
Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.6K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • The kinase associated-1 (KA1) domain is a conserved C-terminal regulatory element in Ser/Thr protein kinases.
  • It is implicated in autoinhibition, membrane binding, and substrate targeting across species.
  • The MARK1 kinase, involved in various cellular processes, is regulated by its KA1 domain.

Purpose of the Study:

  • To determine the crystal structure of the MARK1 kinase/UBA domain bound to its autoinhibitory KA1 domain.
  • To elucidate the molecular mechanism of KA1 domain-mediated autoinhibition in MARK1.
  • To identify potential therapeutic targets based on the structural findings.

Main Methods:

  • X-ray crystallography to determine the high-resolution structure of the MARK1-KA1 complex.
  • Kinetic studies using site-directed mutagenesis to validate the identified binding interface.
  • Comparative analysis with other MARK kinase structures.

Main Results:

  • The crystal structure revealed an unexpected binding interface between the KA1 domain and the MARK1 kinase domain, involving the αD helix and both kinase lobes.
  • Kinetic experiments confirmed the importance of this interface for autoinhibition.
  • The KA1 domain was shown to physically block peptide substrate binding to the MARK1 kinase.

Conclusions:

  • The KA1 domain acts as an autoinhibitory module for MARK1 by directly obstructing substrate access.
  • The study highlights kinase-specific binding modes of KA1 domains, offering insights into differential regulation.
  • The findings provide a structural basis for developing therapeutics targeting MARK1 and related kinases in diseases like Alzheimer's and cancer.